HERITAGE INVESTORS MANAGEMENT CORP - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
HERITAGE INVESTORS MANAGEMENT CORP ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$1,910
-6.1%
123,459
-4.6%
0.08%
-1.2%
Q2 2023$2,033
-20.9%
129,436
-17.0%
0.08%
-26.4%
Q1 2023$2,569
-4.2%
155,907
-9.3%
0.11%
-9.8%
Q4 2022$2,682
-99.9%
171,943
-9.3%
0.12%
-1.6%
Q3 2022$2,458,000
-24.6%
189,513
-18.4%
0.12%
-19.0%
Q2 2022$3,261,000
-4.4%
232,283
-2.5%
0.15%
+11.7%
Q1 2022$3,412,000
-1.6%
238,238
-6.3%
0.14%
+1.5%
Q4 2021$3,466,000
-44.2%
254,325
-33.0%
0.14%
-48.3%
Q3 2021$6,216,000
+1.8%
379,513
+4.6%
0.26%
+2.0%
Q2 2021$6,108,000
+3.2%
362,947
+12.0%
0.26%
-2.3%
Q1 2021$5,917,000
+0.1%
324,029
-0.2%
0.26%
-6.4%
Q4 2020$5,910,000
+3.2%
324,706
+1.1%
0.28%
-9.1%
Q3 2020$5,727,000
+3.5%
321,033
+4.1%
0.31%
-4.0%
Q2 2020$5,531,000
+20.2%
308,482
+1.7%
0.32%
-0.6%
Q1 2020$4,603,000
-23.3%
303,260
-0.3%
0.32%
+1.6%
Q4 2019$6,000,000
+24.2%
304,089
+8.3%
0.32%
+15.2%
Q3 2019$4,830,000
+4.2%
280,840
+7.2%
0.28%
+3.8%
Q2 2019$4,636,000
+24.5%
261,898
+43.2%
0.27%
+19.8%
Q1 2019$3,724,000182,8350.22%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2020
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders